InvestorsHub Logo
Followers 22
Posts 3646
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Tuesday, 10/05/2021 8:42:24 AM

Tuesday, October 05, 2021 8:42:24 AM

Post# of 7502
Two items:

A. Botox war: East Bay challenger sued by maker of blockbuster cosmetic toxin [**follow discussion on Biotech Values board]

Basically -

"We believe the alleged patent issues asserted by Allergan in this case are not infringed upon by Revance or our supply source partner Ajinomoto or are invalid," Revance said in a statement. "We are confident in the strength of our intellectual property and have done and will vigorously defend these allegations."

The lawsuit is one of several Allergan has filed against companies threatening to cut in on its aesthetics and therapeutics applications for Botox. Revance said lawsuits are "a frequent tactic" Allergan uses to "distract their competitors."

"If anything, we believe it speaks to Allergan's concern of how impactful our differentiated product will be in the market once approved," Revance said.

https://www.bizjournals.com/sanfrancisco/news/2021/10/04/botox-allergan-revance-daxi-frown-lines-ajinomoto.html?ana=TRUEANTHEMTWT_FR&csrc=6398&taid=615bf7fd76ce460001396e2b&utm_campaign=trueAnthem%3A+Trending+Content&utm_medium=trueAnthem&utm_source=twitter

B. Fosun concludes patient enrollment for Ph 3

https://twitter.com/medtechmd/status/1445013357044453378/photo/1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News